Navigation Links
Pharma CI Conference Amy Yueh Pays $52,000 to Apaporis LLC to Satisfy Judgment Against Her In Superior Court Of New Jersey Case
Date:1/26/2010

TEANECK, N.J., Jan. 26 /PRNewswire/ -- Amy Yueh, the organizer of the Pharma CI Conference, who was sued in 2008 for alleged misappropriation of her employer's assets, has made payment of $52,000 by court order following judgment entered against her in the Superior Court of New Jersey. Yueh's trial took place in Hackensack, NJ.

Ellen Koblitz, Presiding Judge of the Superior Court of New Jersey stated in her ruling that Yueh "clearly took advantage of her employer by misleading 2008 conference participants." The decision represents compensation for "lost opportunity to compete on a level playing field had Yueh left and set up her own conference without misleading the potential participants."

In reaching decision, Judge Koblitz heard 3 1/2 days of testimony by Amy Yueh under questioning by lawyers for the prosecution. The Judge also accepted the introduction of testimony provided in depositions by former SCIP (Society of Competitive Intelligence Professionals) Presidents Cliff Kalb and Martha Matteo.

Yueh's motion to introduce testimony by Steve Levy of Fletcher CSI and her sister, Kelly Yueh, was denied by Judge Koblitz.

As part of the pre-trial proceedings counsel at Pfizer, Johnson & Johnson, Merck, sanofi-aventis, Bristol-Myers Squibb, and Novartis were subpoenaed in request of files detailing Yueh's email communications with various employees within the companies. The drug firms were helpful and the information provided was also recovered from her computer by forensic experts.

Previous articles and press releases on the case may be found at:

http://news.findlaw.com/prnewswire/20080813/13aug20080904.html

http://www.genengnews.com/news/bnitem.aspx?name=41654272

http://www.prnewswire.com/news-releases/50000-judgment-entered-against-defendant-amy-yueh-pharma-ci-conference-organizer-in-superior-court-of-new-jersey-62134257.html

http://www.njbiz.com/article.asp?aID=79155

Amy Yueh revealed in court documents that the 2008 Pharma CI Conference had revenues of $417,145 and net profits of $285,156.

The legal action was initiated in the Superior Court of New Jersey against Amy Yueh and her companies Acralinx Agenda and Amintell LLC.

Further litigation is pending.

CONTACT:  Mark Alexay, +1-201-452-4023, malexay@pharmabiotechci.com

SOURCE Apaporis LLC


'/>"/>
SOURCE Apaporis LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... februari 2016 AAIPharma Services Corp./Cambridge ... van productie en ontwikkeling op maat voor ... een uitbreiding aan van steriele vul- en ... Charleston, SC . Substantiële ... recente investeringen. http://photos.prnewswire.com/prnh/20150806/256637LOGO ...
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
(Date:2/11/2016)... -- Stem cells are primitive cells found in all ... capacity to differentiate into mature cell types Stem cells ... mouse embryonic stem cells were derived from embryos in ... first culturing of embryonic stem cells from non-human primates ... 2006 As a result of these discoveries, stem cells ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... Erlanger Agency has announced ... Columbus, OH area. The latest campaign focuses on the fight against breast cancer, fundraising ... now being accepted here . , Carmen is a loving single mother of ...
(Date:2/12/2016)... ... February 12, 2016 , ... For Coast Dental dentist Everet ... RDH, and dental assistant Terrell Moore shortly before 7 a.m. to volunteer at Friday’s ... professionals, donating their time and skills to help hundreds of uninsured and underinsured people ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... High-Cost Drug Categories: Strategies for Health Plans and PBMs,” an upcoming Feb. 24 ... maintain affordability and access in big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis ...
(Date:2/12/2016)... ... ... Healthcare careers in the medical laboratory, nursing, and in the imaging field topped ... leader Aureus Medical Group during the month of January. Aureus Medical specializes in placing ... in travel and direct hire opportunities in other allied health fields. , The jobs ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Basketball is ... and integral part of the Peety PoppersTM series, sign language translation is featured in ... of health and wellness in Peety PoppersTM lessons has a sign language translator to ...
Breaking Medicine News(10 mins):